Compositions that treat or inhibit pathological conditions associated with inflammatory response
申请人:Metaproteomics, LLC
公开号:EP2221052A2
公开(公告)日:2010-08-25
The present invention relates to the use of a composition comprising an effective amount of a compound selected from the group consisting of dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone, and hexahydro-isoadhumulone, in the manufacture of a therapeutic composition for treating or preventing inflammatory or inflammation-associated disorders.
本发明涉及一种组合物的用途,该组合物含有有效量的选自以下组别的化合物:二氢-异胡麻酮、二氢-异胡麻酮、二氢-异胡麻酮、四氢-异胡麻酮、四氢-异胡麻酮、六氢-异胡麻酮、六氢-异胡麻酮和六氢-异胡麻酮、四氢-异胡芦巴内酯、四氢-异胡芦巴内酯、六氢-异胡芦巴内酯、六氢-异胡芦巴内酯和六氢-异胡芦巴内酯。